Brief: Weiss Asset Management Reports 11.79% Stake In Theravance Biopharma
12/04/2023 18:57
April 12 (Reuters) - Theravance Biopharma Inc TBPH.O :
* WEISS ASSET MANAGEMENT LP REPORTS 11.79% STAKE IN
THERAVANCE
BIOPHARMA INC AS OF APRIL 11 - SEC FILING
* WEISS ASSET MANAGEMENT LP - PURCHASED THERAVANCE
BIOPHARMA'S
SHARES FOR INVESTMENT, BASED ON BELIEF THAT SHARES ARE
"UNDERVALUED"
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy